141
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Chitosan self-assembled polymeric nanoparticles for percutaneous delivery of betamethasone in contact dermatitis

, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1310-1317 | Received 21 Mar 2021, Accepted 08 Sep 2021, Published online: 15 Oct 2021

References

  • Brasch J, Becker D, Aberer W, et al. Guideline contact dermatitis: S1-guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKI), the Working Group for Occupational and Environmental Dermatology (ABD) of the DDG, the Medical Association of German Allergologists (AeDA), the Professional Association of German Dermatologists (BVDD) and the DDG. Allergo J Int. 2014;23(4):126–138.
  • Agner T, Andersen KE, Brandao FM, et al. Hand eczema severity and quality of life: a cross-sectional, multicentre study of hand eczema patients. Contact Dermatitis. 2008;59(1):43–47.
  • Ahlström MG, Thyssen JP, Wennervaldt M, et al. Nickel allergy and allergic contact dermatitis: a clinical review of immunology, epidemiology, exposure, and treatment. Contact Dermatitis. 2019;81(4):227–241.
  • Lim HW, Collins SAB, Resneck JS, et al. A risk adjustment approach to estimating the burden of skin disease in the United States. J Am Acad Dermatol. 2018;78(1):129–140.
  • Lim HW, Collins SAB, Resneck JS, et al. The burden of skin disease in the United States. J Am Acad Dermatol. 2017;76(5):958–972.e2.
  • Lim HW, Collins SAB, Resneck JS, et al. Contribution of health care factors to the burden of skin disease in the United States. J Am Acad Dermatol. 2017;76(6):1151–1160.e21.
  • Schram SE, Warshaw EM, Laumann A. Nickel hypersensitivity: a clinical review and call to action. Int J Dermatol. 2010;49(2):115–125.
  • Saito M, Arakaki R, Yamada A, et al. Molecular mechanisms of nickel allergy. IJMS. 2016;17(2):202.
  • Krecisz B, Chomiczewska D, Palczynski C, et al. Contact allergy to metals in adolescents: nickel release from metal accessories 7 years after the implementation of the EU Nickel Directive in Poland. Contact Dermatitis. 2012;67(5):270–276.
  • Biesterbos J, Yazar K, Lidén C. Nickel on the Swedish market: follow-up 10 years after entry into force of the EU Nickel Directive. Contact Dermatitis. 2010;63(6):333–339.
  • Biesterbos J, Lidén C, Van Der Valk P. Nickel on the Dutch market: 10 years after entry into force of the EU Nickel Directive. Contact Dermatitis. 2011;65(2):115–117.
  • Habif T. Clinical dermatology: a color guide to diagnosis and therapy. 6th ed. St. Louis (MO): Elsevier; 2016.
  • Damiani G, Eggenhöffner R, Pigatto PDM, et al. Nanotechnology meets atopic dermatitis: current solutions, challenges and future prospects. Insights and implications from a systematic review of the literature. Bioact Mater. 2019;4:380–386.
  • Hussain Z, Katas H, Mohd Amin MCI, et al. Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model. Int J Pharm. 2013;444(1-2):109–119.
  • Olszewska-Słonina DM, Ma̧Tewski D, Czajkowski R, et al. The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation. Med Sci Monit. 2011;17(9):CR498–CR504.
  • Ponti V, Dianzani MU, Cheeseman K, et al. Studies on the reduction of nitroblue tetrazolium chloride mediated through the action of NADH and phenazine methosulphate. Chem Biol Interact. 1978;23(3):281–291.
  • Durak I, Yurtarslanl Z, Canbolat O, et al. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta. 1993;214(1):103–104.
  • Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 1991;196(2–3):143–151.
  • Gouma E, Simos Y, Verginadis I, et al. A simple procedure for estimation of total body surface area and determination of a new value of Meeh's constant in rats. Lab Anim. 2012;46(1):40–45.
  • Eisen M, Kaur S, Rehema A, et al. Allergic contact dermatitis is accompanied by severe abnormal changes in antioxidativity of blood. Biomed Pharmacother. 2004;58(4):260–263.
  • Kaur S, Zilmer K, Leping V, et al. Allergic contact dermatitis is associated with significant oxidative stress. Dermatol Res Pract. 2014;2014:1–7.
  • Nakai K, Yoneda K, Kubota Y. Oxidative stress in allergic and irritant dermatitis: from basic research to clinical management. Recent Pat Inflamm Allergy Drug Discov. 2012;6(3):202–209.
  • Beigh SA, Soodan JS, Nazki S, et al. Oxidative stress, hematobiochemical parameters, trace elements and vitamins in dogs with zinc responsive dermatosis. Vet Arh. 2014;84:591–600.
  • Jaques J. D S, Rezer JFP, Ruchel JB, et al. An experimental model of contact dermatitis: evaluation of the oxidative profile of wistar rats treated with free and nanoencapsulated clobetasol. Redox Rep. 2012;17(5):206–213.
  • Kapun AP, Salobir J, Levart A, et al. Oxidative stress markers in canine atopic dermatitis. Res Vet Sci. 2012;92(3):469–470.
  • Yu K, Wang Y, Wan T, et al. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose. Int J Nanomedicine. 2018;13:129–142.
  • Siddique MI, Katas H, Amin MCIM, et al. Minimization of local and systemic adverse effects of topical glucocorticoids by nanoencapsulation: in vivo safety of hydrocortisone-hydroxytyrosol loaded chitosan nanoparticles. J Pharm Sci. 2015;104(12):4276–4286.
  • Siddique MI, Katas H, Amin MCIM, et al. In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis. Int J Pharm. 2016;507(1–2):72–82.
  • Siddique MI, Katas H, Jamil A, et al. Potential treatment of atopic dermatitis: tolerability and safety of cream containing nanoparticles loaded with hydrocortisone and hydroxytyrosol in human subjects. Drug Deliv Transl Res. 2019;9(2):469–481.
  • Md S, Kuldeep Singh JKA, Waqas M, et al. Nanoencapsulation of betamethasone valerate using high pressure homogenization–solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting. Drug Dev Ind Pharm. 2019;45(2):323–332.
  • Hussain Z, Katas H, Amin MCIM, et al. Antidermatitic perspective of hydrocortisone as chitosan nanocarriers: an ex vivo and in vivo assessment using an NC/Nga mouse model. J Pharm Sci. 2013;102(3):1063–1075.
  • Hussain Z, Katas H, Amin MCIM, et al. Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisone loaded chitosan nanoparticles. Int J Nanomedicine. 2014;9:5143–5156.
  • Hussain Z, Katas H, Amin MCIM, et al. Efficient immuno-modulation of TH1/TH2 biomarkers in 2,4-dinitrofluorobenzene-induced atopic dermatitis: nanocarrier-mediated transcutaneous co-delivery of anti-inflammatory and antioxidant drugs. PLoS One. 2014;9(11):e113143.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.